Skip to main content

Cytomel

NDC 60793-116 · Pfizer Laboratories Div Pfizer Inc

Generic nameliothyronine sodium
Dosage formTABLET
RouteORAL
Active ingredient(s)LIOTHYRONINE SODIUM
Strength25 ug/1
Pharmacologic classTriiodothyronine [CS], l-Triiodothyronine [EPC]
Marketing categoryNDA

Packages

60793-116-01 — 100 TABLET in 1 BOTTLE (60793-116-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42794-133 — Liothyronine Sodium, 43063-884 — Liothyronine Sodium, 50090-3131 — Liothyronine Sodium, 50090-5586 — Liothyronine sodium, 50090-7518 — liothyronine sodium, 51407-384 — Liothyronine Sodium, 59762-1206 — liothyronine sodium, 59762-1207 — liothyronine sodium, 59762-1208 — liothyronine sodium, 60793-115 — liothyronine sodium, 60793-117 — liothyronine sodium, 62756-589 — liothyronine sodium, 62756-590 — liothyronine sodium, 62756-591 — liothyronine sodium, 68071-3571 — Liothyronine Sodium, 68382-582 — Liothyronine sodium, 68382-583 — Liothyronine sodium, 68382-584 — Liothyronine sodium, 68788-7269 — Liothyronine Sodium, 70377-114 — Liothyronine sodium, +30 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T38.1X1 — Poisoning by thyroid hormones and substitutes, accidental (unintentional), T38.1X2 — Poisoning by thyroid hormones and substitutes, intentional self-harm, T38.1X3 — Poisoning by thyroid hormones and substitutes, assault, T38.1X4 — Poisoning by thyroid hormones and substitutes, undetermined, T38.1X5 — Adverse effect of thyroid hormones and substitutes, T38.1X6 — Underdosing of thyroid hormones and substitutes

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels